Literature DB >> 17420350

Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.

Masahiro Kikuya1, Tine W Hansen, Lutgarde Thijs, Kristina Björklund-Bodegård, Tatiana Kuznetsova, Takayoshi Ohkubo, Tom Richart, Christian Torp-Pedersen, Lars Lind, Hans Ibsen, Yutaka Imai, Jan A Staessen.   

Abstract

BACKGROUND: Current diagnostic thresholds for ambulatory blood pressure (ABP) mainly rely on statistical parameters derived from reference populations. We determined an outcome-driven reference frame for ABP measurement. METHODS AND
RESULTS: We performed 24-hour ABP monitoring in 5682 participants (mean age 59.0 years; 43.3% women) enrolled in prospective population studies in Copenhagen, Denmark; Noorderkempen, Belgium; Ohasama, Japan; and Uppsala, Sweden. In multivariate analyses, we determined ABP thresholds, which yielded 10-year cardiovascular risks similar to those associated with optimal (120/80 mm Hg), normal (130/85 mm Hg), and high (140/90 mm Hg) blood pressure on office measurement. Over 9.7 years (median), 814 cardiovascular end points occurred, including 377 strokes and 435 cardiac events. Systolic/diastolic thresholds for optimal ABP were 116.8/74.2 mm Hg for 24 hours, 121.6/78.9 mm Hg for daytime, and 100.9/65.3 mm Hg for nighttime. Corresponding thresholds for normal ABP were 123.9/76.8, 129.9/82.6, and 110.2/68.1 mm Hg, respectively, and those for ambulatory hypertension were 131.0/79.4, 138.2/86.4, and 119.5/70.8 mm Hg. After rounding, approximate thresholds for optimal ABP amounted to 115/75 mm Hg for 24 hours, 120/80 mm Hg for daytime, and 100/65 mm Hg for nighttime. Rounded thresholds for normal ABP were 125/75, 130/85, and 110/70 mm Hg, respectively, and those for ambulatory hypertension were 130/80, 140/85, and 120/70 mm Hg.
CONCLUSIONS: Population-based outcome-driven thresholds for optimal and normal ABP are lower than those currently proposed by hypertension guidelines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420350     DOI: 10.1161/CIRCULATIONAHA.106.662254

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  71 in total

Review 1.  Epidemiology of hypertensive kidney disease.

Authors:  Suneel Udani; Ivana Lazich; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2010-11-16       Impact factor: 28.314

2.  Will generic hypertension guidelines reduce the proliferation of directives?

Authors:  Jan A Staessen; Eoin O'Brien
Journal:  Heart       Date:  2007-07       Impact factor: 5.994

3.  Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure.

Authors:  Hisako Ushio; Tomoaki Ishigami; Naomi Araki; Shintaro Minegishi; Koichi Tamura; Yasuko Okano; Kazuaki Uchino; Osamu Tochikubo; Satoshi Umemura
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

4.  Diagnostic Thresholds for Blood Pressure Measured at Home in the Context of the 2017 Hypertension Guideline.

Authors:  Wanpen Vongpatanasin; Colby Ayers; Hamza Lodhi; Sandeep R Das; Jarett D Berry; Amit Khera; Ronald G Victor; Feng-Chang Lin; Anthony J Viera; Yuichiro Yano; James A de Lemos
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

5.  Out-of-Clinic Blood Pressure Thresholds for Diagnosing and Managing Hypertension, Filling an Important Evidence Gap.

Authors:  Paul Muntner; Daichi Shimbo
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

6.  Rationale for Ambulatory and Home Blood Pressure Monitoring Thresholds in the 2017 American College of Cardiology/American Heart Association Guideline.

Authors:  Paul Muntner; Robert M Carey; Kenneth Jamerson; Jackson T Wright; Paul K Whelton
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

7.  Ambulatory blood pressure monitoring in children: imperfect yet essential.

Authors:  Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-08-25       Impact factor: 3.714

8.  Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension.

Authors:  Abdullah Shehab; Abdishakur Abdulle
Journal:  BMC Cardiovasc Disord       Date:  2011-01-11       Impact factor: 2.298

9.  Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New American College of Cardiology/American Heart Association Classification of Hypertension.

Authors:  Yi-Bang Cheng; Lutgarde Thijs; Zhen-Yu Zhang; Masahiro Kikuya; Wen-Yi Yang; Jesus D Melgarejo; José Boggia; Fang-Fei Wei; Tine W Hansen; Cai-Guo Yu; Kei Asayama; Takayoshi Ohkubo; Eamon Dolan; Katarzyna Stolarz-Skrzypek; Sofia Malyutina; Edoardo Casiglia; Lars Lind; Jan Filipovský; Gladys E Maestre; Yutaka Imai; Kalina Kawecka-Jaszcz; Edgardo Sandoya; Krzysztof Narkiewicz; Yan Li; Eoin O'Brien; Ji-Guang Wang; Jan A Staessen
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

10.  Intrathecal fentanyl abolishes the exaggerated blood pressure response to cycling in hypertensive men.

Authors:  Thales C Barbosa; Lauro C Vianna; Igor A Fernandes; Eliza Prodel; Helena N M Rocha; Vinicius P Garcia; Natalia G Rocha; Niels H Secher; Antonio C L Nobrega
Journal:  J Physiol       Date:  2016-01-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.